Pharmacy

BlueCross BlueShield of Tennessee will stop covering the prescription opioid OxyContin beginning January 1, 2019.

Drugmakers increased the price of 60 products August — a sharp decline from July, which saw 110 price increases, according to a Wells Fargo drug-pricing report.

Despite public outrage over the high cost of insulin and drugmaker promises to halt price increases, they continued to climb from 2017 to 2018, according to a GoodRx analysis.

In an effort to increase drug price transparency, the Senate passed a bill that would ban Medicare insurers from writing gag clauses into their contracts with pharmacists, according to The Washington Examiner.

Medical device and drug recalls, whether voluntary or forced by the FDA, ensure patient safety.

To find financial wiggle room to compete with larger rivals, Bayer is considering job cuts and outsourcing, a person familiar with the discussion told Reuters.

On average, hospitals mark up prescription drugs by 479 percent, according to a new report from PhRMA, the drug industry's main lobbying group.

Camber Pharmaceuticals issued a voluntary recall of one lot of its Montelukast sodium tablets after the bottles were found to contain the wrong drug.

The FDA is expanding its investigation into valsartan heart drugs, which are used to control blood pressure and prevent heart failure, after discovering an ingredient used in the products is  a probable human carcinogen.

In a move expected to save the health system $23 million annually, Boston-based Partners HealthCare has launched its own specialty pharmacy, according to The Boston Business Journal.